97305 ⎘
Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies functional in the cytoplasm, the inner aspect of the cell membrane, the nucleus or the mitochondria
Binding Proteins 1
#2P97-BASE PROTAC ANTIBODY CONJUGATES AND METHODS OF USE
#3TAU THERAPY
#4ANTIBODIES
#5THERAPEUTIC SINGLE DOMAIN ANTIBODY
#6Binding proteins 1
#7INTRABODIES TARGETING POST-TRANSLATIONAL MODIFICATIONS OF NATIVE PROTEINS AND METHOD FOR OBTAINING THEM
#8ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM
#9Antibodies and fragments thereof that bind hepatitis B virus protein X
#10ANTIBODY INHIBITING ACTIVATED RAS IN CELL BY INTERNALIZING INTO CYTOSOL OF CELL, AND USE THEREOF
#11AN ANTI-APOPTOTIC FUNCTION OF PKM2 AND INTRACELLULARLY EXPRESSED SCFV ANTIBODIES
#12Binding proteins 1
#13IMMUNOGLOBULIN FRAMEWORKS WHICH DEMONSTRATE ENHANCED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND METHODS OF IDENTIFYING SAME
#14Intrabodies targeting post-translational modifications of native proteins and method for obtaining them
#15Antibodies and fragments thereof that bind hepatitis B virus protein X
#16Cytosol-penetrating antibody and use thereof
#17Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
#18Polyethylenimine (PEI)-polypeptide conjugates and methods of use thereof
#19TDP-43-binding polypeptides useful for the treatment of neurodegenerative diseases
#20Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same
#21Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
#22Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutations
#23Intranuclear protein transduction through a nucleoside salvage pathway
#24Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
#25Anti-GAP43 antibody
#26Nucleic acid assembly, vector, cell, methods and kit thereof
#27Soluble polypeptides
#28CELL-PENETRATING, SEQUENCE-SPECIFIC AND NUCLEIC ACID-HYDROLYZING ANTIBODY, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#29ANTI-NUCLEIC ACID ANTIBODY INDUCING CELL DEATH OF CANCER CELLS AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME
#30Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates
#31ANTIBODY CONJUGATES FOR CIRCUMVENTING MULTI-DRUG RESISTANCE
#32ANTI HER2/NEU ANTIBODY
#33Anti-apoptotic protein antibodies
#34ELECTRODE, METHOD OF MAKING SAME, PHOTOELECTRIC TRANSFER ELEMENT, METHOD OF MANUFACTURING SAME, ELECTRONIC DEVICE AND METHOD OF MANUFACTURING SAME
#35Dek protein compositions and methods of using the same
#36Intranuclear protein transduction through a nucleoside salvage pathway
#37Compositions and Methods for Modulating DNA Repair
#38Treatment of Neurodegenerative Diseases by the Use of Gpr49
#39Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells
#40MODULATOR OF TNF/NGF SUPERFAMILY RECEPTORS AND SOLUBLE OLIGOMERIC TNF/NGF SUPERFAMILY RECEPTORS
#41Compositions and methods for cancer immunotherapy
#42Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same
#43Method for promoting formation of facultative heterochromatin
#44PenetraBodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases
#45Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
#46Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
#47Methods and compositions related to inhibiting nuclear envelope breakdown
#48Single-domain antibodies and uses thereof
#49Compositions and methods for modulating DNA repair
#50Compositions and methods for modulating cell division